Novel use of dual immunomodulation for treating stiff-person syndrome, cerebellar variant

Mov Disord. 2013 Nov;28(13):1905-6. doi: 10.1002/mds.25574. Epub 2013 Jul 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Cerebellum / pathology*
  • Cyclophosphamide / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Rituximab
  • Stiff-Person Syndrome / immunology
  • Stiff-Person Syndrome / pathology*
  • Stiff-Person Syndrome / therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab
  • Cyclophosphamide